Utilization of TachoSil® vs. Evarrest™ During Inpatient Visits in the United States

White Paper

Utilization of TachoSil^® vs. Evarrest™ During Inpatient Visits in the United States

TachoSil^® and Evarrest™, fibrin sealant patches, are approved for adjunctive use with manual compression when the control of bleeding by standard surgical technique is ineffective or impractical.

This white paper assesses real-world utilization patterns and outcomes of Tachosil^® Fibrin Sealant Patch compared to Evarrest™ Fibrin Sealant Patch in the United States, highlighting how Tachosil^®'s use leads to cost savings, waste reduction, and optimized outcomes.

Download the white paper for the full study analysis and results.

CONTACT INFORMATION

Premier is committed to protecting the privacy and security of any personal information you provide to us. By clicking here, you understand and acknowledge that the personal information that you are submitting on this form is subject to Premier's privacy policy.